Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
81.41B | 91.99B | 88.23B | 69.98B | 59.54B |
Gross Profit | ||||
11.30B | 12.03B | 15.74B | 18.10B | 17.10B |
EBIT | ||||
5.59B | 5.08B | 13.07B | 15.56B | 14.12B |
EBITDA | ||||
8.50B | 10.71B | 14.84B | 17.65B | 15.88B |
Net Income Common Stockholders | ||||
3.18B | 4.29B | 7.66B | 10.48B | 9.19B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.12B | 10.54B | 10.12B | 8.98B | 7.12B |
Total Assets | ||||
148.70B | 157.29B | 163.15B | 140.72B | 112.07B |
Total Debt | ||||
59.24B | 61.39B | 57.70B | 50.70B | 39.92B |
Net Debt | ||||
51.14B | 50.95B | 47.69B | 42.41B | 32.80B |
Total Liabilities | ||||
87.95B | 92.50B | 91.08B | 80.86B | 66.28B |
Stockholders Equity | ||||
53.93B | 57.90B | 63.58B | 51.94B | 39.60B |
Cash Flow | Free Cash Flow | |||
5.28B | 4.07B | 867.30M | -71.24M | -640.85M |
Operating Cash Flow | ||||
11.34B | 10.03B | 9.88B | 8.28B | 6.49B |
Investing Cash Flow | ||||
-7.05B | -7.51B | -12.21B | -8.32B | -9.45B |
Financing Cash Flow | ||||
-5.86B | -1.41B | 3.69B | 865.58M | -2.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $23.46B | 21.14 | 9.00% | 2.27% | 5.90% | 11.85% | |
76 Outperform | $3.00B | 24.80 | 9.00% | 1.96% | 17.72% | 11.33% | |
76 Outperform | $6.66B | 12.19 | 12.22% | 4.83% | -14.01% | ― | |
75 Outperform | $4.94B | 12.29 | 5.56% | 6.54% | -5.19% | 9.01% | |
73 Outperform | $404.33M | 32.30 | 7.99% | 2.00% | -0.82% | -39.38% | |
65 Neutral | $11.67B | 15.52 | 6.23% | 4.52% | 5.50% | -9.06% | |
64 Neutral | $1.66B | 20.31 | 5.91% | 4.74% | -3.71% | -21.36% |